ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

Fischinger Names HHS AIDs Coordinator; DeVita Appoints Maryann Roper Acting Deputy Director

October 30, 1987

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

Clinical Oncology Program Overview Updates Ongoing Trials

December 8, 1989

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980